Meritage Group’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,753
Closed -$230K 62
2023
Q2
$230K Sell
5,753
-541
-9% -$21.5K 0.01% 46
2023
Q1
$247K Sell
6,294
-1,288
-17% -$47.3K 0.01% 35
2022
Q4
$241K Buy
7,582
+156
+2% +$4.7K 0.01% 19
2022
Q3
$211K Buy
+7,426
New +$254K 0.01% 34
2021
Q2
Sell
-3,540
Closed -$226K 43
2021
Q1
$226K Sell
3,540
-3,393
-49% -$197K ﹤0.01% 33
2020
Q4
$363K Buy
+6,933
New +$342K 0.01% 26
2020
Q2
Sell
-9,428
Closed -$366K 41
2020
Q1
$366K Buy
+9,428
New +$480K 0.01% 21

Other funds holding XRAY

Meritage Group's XRAY Position: Q3 2023 in Review

Meritage Group sold out of Dentsply Sirona (XRAY) in Q3 2023, closing a stake of 5,753 shares — an estimated $230K sold.

Meritage Group first reported a position in XRAY in Q1 2020 and held it in 7 quarters. The position peaked at $366K in Q1 2020. 474 funds tracked by Wall St. Rank hold XRAY as of Q3 2023.

  • Meritage Group reported no remaining Dentsply Sirona position as of Q3 2023 after selling out during the quarter.
  • Meritage Group sold 5,753 Dentsply Sirona shares in Q3 2023, an estimated $230K.
  • Meritage Group first reported a position in Dentsply Sirona in Q1 2020 and held it in 7 quarters.
  • Meritage Group's Dentsply Sirona position peaked at $366K in Q1 2020.
  • 474 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2023.

Based on Meritage Group's 13F filing for Q3 2023, filed 13 Nov 2023.